Samsara BioCapital, LLC Diversified Active

Location: Palo Alto, CA

CIK: 0001744967 · Show all filings

Period: Q3 2020 (← Previous) (Next →)

Filing Date: Nov 16, 2020

Total Value: $359M (100.0% shares, 0.0% debt)

Holdings (36)

Forma Therapeutics Holdings, Inc. 20.7%
Value $74.37M Shares 1,492,163 Est. Cost $46.49 Unrealized
NKTX Nkarta, Inc. 17.1%
Value $61.16M Shares 2,034,703 Est. Cost $29.47 Unrealized 0.0%
Iveric Bio, Inc. 5.3%
Value $19.01M Shares 3,370,478 Est. Cost $5.74 Unrealized
Springworks Therapeutics Inc 5.3%
Value $18.97M Shares 398,017 Est. Cost $21.68 Unrealized
CureVac N.V. 4.8%
Value $17.24M Shares 370,385 Est. Cost $46.55 Unrealized
Sutro BioPharma Inc 4.7%
Value $16.84M Shares 1,675,579 Est. Cost $8.61 Unrealized
Intercept Pharmaceuticals Inc 4.7%
Value $16.74M Shares 403,688 Est. Cost $88.27 Unrealized
Allakos Inc 4.4%
Value $15.67M Shares 192,334 Est. Cost $51.45 Unrealized
Unum Therapeutics, Inc. 3.7%
Value $13.29M Shares 5,681,818 Est. Cost $2.34 Unrealized
Syros Pharmaceuticals Inc 3.2%
Value $11.61M Shares 1,407,949 Est. Cost $6.82 Unrealized
Odonate Therapeutics Inc 3.1%
Value $10.95M Shares 815,421 Est. Cost $14.27 Unrealized
Atreca Inc 2.4%
Value $8.627M Shares 617,560 Est. Cost $17.99 Unrealized
Verona Pharma PLC. 1.9%
Value $6.933M Shares 1,111,112 Est. Cost $6.18 Unrealized
Aeglea BioTherapeutics, Inc. 1.7%
Value $6.266M Shares 883,720 Est. Cost $9.25 Unrealized
EQ Equillium, Inc. 1.7%
Value $6.199M Shares 1,074,285 Est. Cost $8.10 Unrealized 0.0%
ACRS Aclaris Therapeutics, Inc. 1.5%
Value $5.534M Shares 2,153,265 Est. Cost $1.36 Unrealized +64.4%
BCTG Acquisition Corp 1.4%
Value $5.18M Shares 500,000 Est. Cost $10.36 Unrealized
RYTM Rhythm Pharmaceuticals Inc 1.4%
Value $5.089M Shares 234,846 Est. Cost $17.90 Unrealized +28.0%
Panacea Acquisition Corp. 1.3%
Value $4.8M Shares 400,000 Est. Cost $12.00 Unrealized
Alpine Immune Sciences Inc 1.2%
Value $4.344M Shares 494,190 Est. Cost $8.79 Unrealized
Kala Pharmaceuticals Inc 0.9%
Value $3.384M Shares 451,162 Est. Cost $9.52 Unrealized
Albireo Pharma, Inc. 0.9%
Value $3.337M Shares 100,000 Est. Cost $33.37 Unrealized
GERN Genron Corporation 0.7%
Value $2.664M Shares 1,531,088 Est. Cost $1.49 Unrealized +23.7%
Allovir, Inc 0.7%
Value $2.504M Shares 91,057 Est. Cost $27.50 Unrealized
NVAX Novavax, Inc. 0.7%
Value $2.347M Shares 21,660 Est. Cost $121.82 Unrealized 0.0%
FULC Fulcrum Therapeutics, Inc. 0.7%
Value $2.332M Shares 294,118 Est. Cost $15.75 Unrealized -23.5%
RCKT Rocket Pharmaceuticals Inc 0.6%
Value $2.278M Shares 99,643 Est. Cost $19.67 Unrealized +25.2%
Aimmune Therapeutics, Inc. 0.6%
Value $2.003M Shares 58,142 Est. Cost $14.42 Unrealized
Catabasis Pharmaceuticals Inc 0.5%
Value $1.857M Shares 300,000 Est. Cost $4.37 Unrealized
SPRO Spero Therapeutics, Inc. 0.5%
Value $1.786M Shares 160,000 Est. Cost $11.83 Unrealized 0.0%
UROV Urovant Sciences Ltd 0.4%
Value $1.471M Shares 157,480 Est. Cost $6.59 Unrealized
Hookipa Pharma Inc 0.3%
Value $1.104M Shares 116,602 Est. Cost $6.73 Unrealized
KALV KalVista Pharmaceuticals Inc 0.3%
Value $1.059M Shares 84,087 Est. Cost $18.15 Unrealized -31.1%
BNTX BioNTech SE 0.2%
Value $879K Shares 12,700 Est. Cost $69.21 Unrealized
NGM Biopharmaceuticals, Inc. 0.2%
Value $580K Shares 36,451 Est. Cost $19.73 Unrealized
Amarin Corp PLC 0.0%
Value $105K Shares 25,000 Est. Cost $4.00 Unrealized